PharmD Info

A forum for Indian Pharmacy Professionals

GPAT Questions, B Pharm/M Pharm/PharmD Course Study Materials and Notes, Online Courses, Drug Inspector Exams, Higher Studies, Group Discussions
Forum rules: Dear User, Kindly read our forum rules before you proceed with our PharmD Info, Your first 5 posts/topics requires moderator approval and this website is purely meant for educational and knowledge sharing purpose only so you should not make any topics/replies/messages which criticize, threaten or abuse any member, pharmacy governing bodies and organizations. Your post will be deleted automatically by our BB Pruning System if your topic is not viewed by members for more than 5 days. So, make sure that your topics and its related contents are unique and valuable. We expect you to be an active member of our forum to continue with your free membership.Kindly note that if a member received more than five warnings from moderator/members they will be blocked automatically by our Bulletin Board system.
  • User avatar
#2032
Drug-eluting stents (DES) were designed to reduce in-stent neointimal proliferation, and thus,minimise in-stent restenosis (ISR), which is the major disadvantage of percutaneous coronary interventions with bare-metal stents (BMS). DES have revolutionised the treatment of coronary artery disease by reducing the rate of ISR from 20-40% with BMS to 6-8% with DES.

In recent years, however, concern has been raised regarding the long-term safety of DES and the risk of stent thrombosis (ST) and late restenosis due to neoatherosclerosis. This potential increased risk remains an area of uncertainty in the field of interventional cardiology.

DES consist of a standard metallic stent, a polymer coating, and an antiproliferative drug that is embedded within a durable or biodegradable (bioabsorbable) polymer and released over time. Although the common basic concept of DES remains constant, all DES are not made equal and each type may vary significantly with respect to deliverability, efficacy, and safety.

Image


Image
Similar Topics
Topics Statistics Last post
0 Replies 
3267 Views
by Admin
05 Jan 2020, 08:59
0 Replies 
2499 Views
by Admin
06 Oct 2016, 16:59
‘9% of kids with TB resistant to key drug’
by Prajith  - 19 Nov 2015, 12:43  - In: Pharma News
0 Replies 
1324 Views
by Prajith
19 Nov 2015, 12:43
0 Replies 
1599 Views
by Prajith
28 Aug 2016, 09:15
Drug profile Format- Example
by Admin  - 04 Dec 2018, 10:59  - In: Pharmacy Practice
0 Replies 
6174 Views
by Admin
04 Dec 2018, 10:59

Pharmacy Council of India circulated this guidelin[…]

Medical writing helps in developing impactful pati[…]

This document is intended for clinicians taking ca[…]

You can also mention here PillsBills. An online s[…]

E-Learn Portal